Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: Shanghai
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Harbin Pharmaceutical Group Co Ltd

+ Add to Watchlist

600664:CH

8.680 CNY 0.190 2.14%

As of 02:05:14 ET on 12/30/2014.

Trading has been suspended for 600664:CH

Snapshot for Harbin Pharmaceutical Group Co Ltd (600664)

Open: 8.850 Day's Range: 8.610 - 8.950 Volume: 27,033,685
Previous Close: 8.870 52wk Range: 5.570 - 9.100 1-Yr Rtn: -

Stock Chart for 600664

No chart data available.
  • 600664:CH 8.690
  • 1D
  • 1M
  • 1Y
8.870
Interactive 600664 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 600664

Current P/E Ratio (ttm) 71.8091
Estimated P/E(12/2014) -
Relative P/E vs. SHASHR 4.6702
Earnings Per Share (CNY) (ttm) 0.1209
Est. EPS (CNY) (12/2014) -
Est. PEG Ratio -
Market Cap (M CNY) 16,643.75
Shares Outstanding (M) 1,917.48
30 Day Average Volume 8,368,921
Price/Book (mrq) 1.9935
Price/Sale (ttm) 0.9614
Dividend Indicated Gross Yield 0.76%
Cash Dividend (CNY) 0.0660
Dividend Ex-Date 08/26/2014
5 Year Dividend Growth -32.00%
Next Earnings Announcement 02/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 600664

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 600664

Harbin Pharmaceutical Group Co., Ltd. develops and manufactures a variety of medicines, preparations, Chinese traditional medicines, healthcare products, and biopharmaceuticals. The Company's main products include penicillin, calcium gluconate, etc.

Zhang LijunChairman/PresidentMeng XiaodongVP/Secretary
Wu ZhijunVice PresidentSha MeiVice President
More Company Profile & Key Executives for 600664

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil